Bayer AG (BAYER)
Budapest Stock Exchange · Hungary · prices in HUF · close of 22 Oct 2026
Key indicators
| Last close | HUF 16,110.00 |
|---|---|
| 52-week range | 10,100.00 – 18,890.00 |
| Return, 1 month / 3 months | −9.9% / −5.2% |
| Return, 1 year / 3 years | +50.6% / +2.5% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 39 |
| Volatility (1 year) | 43.6% |
| Worst drawdown (1 year) | -36.6% |
| Average daily value traded | 0.44M HUF |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Bayer AG is a German life sciences company based in Leverkusen. It develops and makes prescription medicines, including treatments for cancer, heart conditions and eye disease, and it supplies vaccines and other pharmaceutical products to hospitals, clinics and doctors. Its crop science business provides seeds, traits and crop protection products to farmers, while its consumer health arm offers over-the-counter remedies such as pain relievers, cold treatments and vitamins to pharmacies and retailers around the world.
On this site Bayer AG appears as a stock on the Budapest Stock Exchange (Hungary), code BAYER, with prices in Hungarian forint (HUF). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Bayer AG (BAYER) trades on the Budapest Stock Exchange in Hungary. It last closed at HUF 16,110.00 on 22 October 2026.
Its price-based Market X-Ray is 57 out of 100 (a fair price profile), ranking 15 of 42 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 50.6% and over the last three months it fell 5.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Budapest Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 83 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 2.5% | ||
| From 52-week high | -14.0% | ||
| Momentum | 80 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | -5.2% | ||
| 6-month return | 7.0% | ||
| 12-month return, skipping the last month | 67.1% | ||
| Stability (higher is calmer) | 35 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 43.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -36.6% | ||
| Liquidity | 12 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.44M HUF | ||
| Zero-volume days | 51.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −2.5% |
|---|---|
| 1 month | −9.9% |
| 3 months | −5.2% |
| 6 months | +7.0% |
| 1 year | +50.6% |
| 3 years | +2.5% |
| 5 years | −0.5% |
Signals
| 50-day / 200-day average | 17,366.70 / 15,715.33 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 229.92 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 Apr 2025 | EUR 44.4895 |
| 29 Apr 2024 | EUR 43.0265 |
| 2 May 2023 | EUR 897.3361 |
| 2 May 2022 | EUR 761.9100 |
| 28 Apr 2021 | EUR 723.8101 |
| 29 Apr 2020 | EUR 994.9941 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Budapest Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.